Enhanced IL-2 in early life limits the development of TFH and protective antiviral immunity
File(s)jem_20201555.pdf (6.22 MB) Revised Supplemental Figures.pdf (1.25 MB)
Published version
Supplementary information
Author(s)
Type
Journal Article
Abstract
T follicular helper cell (TFH)-dependent antibody responses are critical for long-term immunity. Antibody responses are diminished in early life, limiting long-term protective immunity and allowing prolonged or recurrent infection, which may be important for viral lung infections that are highly prevalent in infancy. In a murine model using respiratory syncytial virus (RSV), we show that TFH and the high-affinity antibody production they promote are vital for preventing disease on RSV reinfection. Following a secondary RSV infection, TFH-deficient mice had significantly exacerbated disease characterized by delayed viral clearance, increased weight loss, and immunopathology. TFH generation in early life was compromised by heightened IL-2 and STAT5 signaling in differentiating naive T cells. Neutralization of IL-2 during early-life RSV infection resulted in a TFH-dependent increase in antibody-mediated immunity and was sufficient to limit disease severity upon reinfection. These data demonstrate the importance of TFH in protection against recurrent RSV infection and highlight a mechanism by which this is suppressed in early life.
Date Issued
2021-12-06
Date Acceptance
2021-09-23
Citation
Journal of Experimental Medicine, 2021, 218 (12)
ISSN
0022-1007
Publisher
Rockefeller University Press
Journal / Book Title
Journal of Experimental Medicine
Volume
218
Issue
12
Copyright Statement
© 2021 Pyle et al. This article is available under a Creative Commons License (Attribution 4.0 International, as described at https://creativecommons.org/licenses/by/4.0/).
License URL
Sponsor
Wellcome Trust
Asthma UK
National Heart & Lung Institute Foundation
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/34665220
PII: 212711
Grant Number
101372/Z/13/Z
Asthma UK Centre
Students 2016-19
Subjects
Immunology
11 Medical and Health Sciences
Publication Status
Published
Coverage Spatial
United States
Article Number
ARTN e20201555
Date Publish Online
2021-10-19